Steward Partners Investment Advisory’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7K Sell
551
-95
-15% -$3.52K ﹤0.01% 3289
2025
Q4
$27.2K Hold
646
﹤0.01% 2999
2025
Q3
$22.2K Buy
+646
New +$18.5K ﹤0.01% 3049
2023
Q2
Sell
-65
Closed -$1.45K 3393
2023
Q1
$1.45K Hold
65
﹤0.01% 3075
2022
Q4
$1.54K Hold
65
﹤0.01% 3068
2022
Q3
$1K Hold
65
﹤0.01% 3177
2022
Q2
$1K Hold
65
﹤0.01% 3177
2022
Q1
$2K Hold
65
﹤0.01% 3118
2021
Q4
$3K Hold
65
﹤0.01% 2974
2021
Q3
$3K Hold
65
﹤0.01% 2953
2021
Q2
$3K Hold
65
﹤0.01% 6806
2021
Q1
$3.49K Hold
65
﹤0.01% 3099
2020
Q4
$3K Hold
65
﹤0.01% 2660
2020
Q3
$2K Hold
65
﹤0.01% 2608
2020
Q2
$2K Hold
65
﹤0.01% 2500
2020
Q1
$1K Hold
65
﹤0.01% 2434
2019
Q4
$1K Hold
65
﹤0.01% 2542
2019
Q3
$1K Buy
+65
New +$1.73K ﹤0.01% 2559

Other funds holding VCYT

Steward Partners Investment Advisory's VCYT Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Veracyte (VCYT) stake by 15% in Q1 2026, selling an estimated $3.52K and leaving 551 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

Steward Partners Investment Advisory first reported a position in VCYT in Q3 2019 and has held it in 18 quarters since. The position peaked at $27.2K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Steward Partners Investment Advisory held 551 shares of Veracyte worth $17.7K as of Q1 2026.
  • Steward Partners Investment Advisory sold 95 Veracyte shares in Q1 2026, an estimated $3.52K.
  • Veracyte made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3289 holding.
  • Steward Partners Investment Advisory first reported a position in Veracyte in Q3 2019 and has held it in 18 quarters since.
  • Steward Partners Investment Advisory's Veracyte position peaked at $27.2K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.